SBI Okasan Asset Management Co.Ltd. bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,500 shares of the financial services provider’s stock, valued at approximately $657,000.
Several other institutional investors also recently bought and sold shares of the stock. Ninety One UK Ltd raised its position in Marsh & McLennan Companies by 163.0% during the 4th quarter. Ninety One UK Ltd now owns 3,542,004 shares of the financial services provider’s stock valued at $657,113,000 after purchasing an additional 2,195,201 shares during the last quarter. Assenagon Asset Management S.A. raised its position in Marsh & McLennan Companies by 9,455.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,520,164 shares of the financial services provider’s stock valued at $282,021,000 after purchasing an additional 1,504,255 shares during the last quarter. Wellington Management Group LLP raised its position in Marsh & McLennan Companies by 9.1% during the 3rd quarter. Wellington Management Group LLP now owns 15,091,478 shares of the financial services provider’s stock valued at $3,041,386,000 after purchasing an additional 1,260,434 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in Marsh & McLennan Companies by 654.7% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,419,104 shares of the financial services provider’s stock valued at $285,992,000 after purchasing an additional 1,231,059 shares during the last quarter. Finally, Invesco Ltd. raised its position in Marsh & McLennan Companies by 29.7% during the 3rd quarter. Invesco Ltd. now owns 3,293,188 shares of the financial services provider’s stock valued at $663,676,000 after purchasing an additional 753,828 shares during the last quarter. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies stock opened at $159.73 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28. The company has a market capitalization of $77.17 billion, a P/E ratio of 19.97, a PEG ratio of 2.32 and a beta of 0.65. The stock’s 50 day moving average is $164.87 and its 200 day moving average is $172.25. Marsh & McLennan Companies, Inc. has a twelve month low of $157.74 and a twelve month high of $235.78.
Insider Buying and Selling at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.38% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of research firms have commented on MRSH. Wells Fargo & Company lowered their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research report on Thursday, April 9th. Mizuho lowered their price target on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research report on Monday, April 13th. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Piper Sandler lowered their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research report on Tuesday. Finally, Barclays decreased their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Marsh & McLennan Companies has a consensus rating of “Hold” and an average target price of $203.56.
Read Our Latest Research Report on MRSH
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
